Ocugen Inc (OCGN) USD ; Open · $ ; Trade high · $ ; Year high · $ ; Previous close · $ ; Trade low · $ Ocugen Inc (OCGN) ; Previous Close ; Volume 1,, ; Avg Vol 3,, ; Stochastic %K · % ; Weighted Alpha + Week of August 26, NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends. Track Ocugen Inc (OCGN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable. Ocugen Inc (OCGN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund.
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines. Ocugen Inc Registered Shs's market capitalization is $ M by M shares outstanding. Is Ocugen stock a Buy, Sell or Hold? Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Valuation: Ocugen, Inc. ; P/E ratio * · EV / Sales * · Yield *. Ocugen has been included in the Lehigh University Pennsylvania Index—a newly established stock index to showcase the economic growth of Pennsylvania. We. Get the latest updates on Ocugen, Inc. Common Stock (OCGN) pre market trades, share volumes, and more. Make informed investments with Nasdaq. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. Get Ocugen, Inc. (OCGN) real-time share value, investment, rating and financial market information from Capital. Friendly Platforms & Trading today. On Friday, Ocugen Inc (OCGN:NAQ) closed at , % below its week high of , set on Mar 25, week range. Today. Oct 26 Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. OCGN - Ocugen, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM).
Stock analysis for Ocugen Inc (OCGN:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Ocugen stock drops after FDA places clinical hold on study of COVID vaccine candidate Covaxin. Shares of Ocugen Inc. sank % premarket, after the. The Investor Relations website contains information about Ocugen, Inc.'s business for stockholders, potential investors, and financial analysts. Looking to buy Ocugen, Inc. Stock? View today's OCGN stock price, trade commission-free, and discuss OCGN stock updates with the investor community. Discover real-time Ocugen, Inc. Common Stock (OCGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Ocugen Inc. analyst ratings, historical stock prices, earnings estimates & actuals. OCGN updated stock price target summary. Ocugen Inc. ; Volume, M ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. The current price of OCGN is USD — it has decreased by −% in the past 24 hours. Watch Ocugen, Inc. stock price performance more closely on the chart. For the upcoming trading day on Tuesday, 3rd we expect Ocugen Inc to open at $, and during the day (based on 14 day Average True Range), to move between.
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline. The Ocugen, Inc stock price today is What Is the Stock Symbol for Ocugen, Inc? The stock ticker symbol for Ocugen, Inc is OCGN. Is OCGN the Same as $OCGN. Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for. Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for. On Friday, Ocugen Inc (OCGN:NAQ) closed at , % below its week high of , set on Mar 25, week range. Today. Oct 26
In a direct offering, eye-drug developer Ocugen sold 3 million shares at $, 46% above Friday's close. The stock leaped on Monday. OCGN. VERICEL CORPORATION. +% ; BIOLIFE SOLUTIONS, INC. % ; JOHNSON & JOHNSON. +% ; CELLECTAR BIOSCIENCES, INC. +%.